# Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation

> **NCT07396220** · NA · ENROLLING_BY_INVITATION · sponsor: **University of California, San Diego** · enrollment: 56 (estimated)

## Conditions studied

- Suicidal Ideation

## Interventions

- **OTHER:** Naturalistic Intranasal Esketamine
- **BEHAVIORAL:** Brief Cognitive Behavioral Therapy for Suicide Prevention

## Key facts

- **NCT ID:** NCT07396220
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-01-09
- **Primary completion:** 2028-01
- **Final completion:** 2029-01
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07396220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07396220, "Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07396220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*